Skip 
Navigation Link
Addictions
Resources
Basic Information
What is Addiction?What Causes Addiction?How Do You Get Addicted?Signs and Symptoms of AddictionTreatment for AddictionReferencesResourcesFrequentlly Asked Questions about Addiction
TestsLatest News
Often, Opioid Abuse Becomes a Family AffairU.S. Courts, Jails Could Be Key Players in Curbing Opioid AbuseSteep Rise in Deaths for People Hospitalized After Opioid ODRisk of Persistent Opioid Use a Concern for Youth After SurgeryFDA Approves Once-Monthly Injection for Opioid AddictionImmediate Access to Opioid Agonists Found Cost-EffectiveOpioid Crisis Hitting Boomers, Millennials HardestTop Anti-Opioid Meds Are Equally Safe, EffectiveAbusing Pot, Booze Lowers Teens' Chances for Success in LifeLethal Dangers Lurk Even After Opioid OD RescueUsing Cocaine? Fingerprints Might TellFentanyl Driving Surge in Fatal U.S. Opioid OverdosesTrump Declares Opioid Epidemic a Public Health EmergencyOpioid Addiction a Danger After Weight-Loss SurgeryU.S. Opioid Painkiller Abuse May Be Leveling OffDrug OD Rate Now Higher in Rural U.S. Than Cities: CDCExtended-Release Naltrexone Promising for Opioid DependenceHealth Tip: Recovering From Substance AbuseMedicare Could Do More to Stem Opioid EpidemicNew Online Tool Aids Search for Alcohol TreatmentHeroin Taking Bigger Share of U.S. Opioid ODsRapid Test for Meth Abuse May Be NearPost-Op Opioids: How Much Is Enough?CDC Launches Opioid Campaign in Hard-Hit StatesERs Prescribing Opioids at Lower Doses, Shorter DurationsAddictive Opioids Common for People on DialysisBooze Often Glorified On YouTube VideosOpioid ODs Have Cut Into U.S. Life Expectancy: CDCAAP: Opioid Dependence/Abuse Public Health Issue for ChildrenSurgery Can Be Trigger for Teen Opioid AbuseFDA Permits Marketing of App to Help Treat Substance AbuseApp to Help Treat Substance Abuse ApprovedFentanyl Drives Rise in Opioid-Linked Deaths in U.S.Opioid Overdoses and Deaths Flooding U.S. HospitalsIncrease in Alcohol Use, High-Risk Drinking in U.S. AdultsAlcohol Use, Abuse on the Rise in U.S.U.S. Opioid Crisis Continues to Worsen'12-Step' Strategy Boosts Success of Teen Drug Abuse ProgramAddiction Drug Underused by Primary Care Docs in U.S.7-Fold Spike Seen in Opioid-Linked Fatal Car CrashesNew Alcohol Screening, Brief Intervention Manual DevelopedOpioid Abuse Down in Younger Americans, But Up Among Older AdultsTreating ADHD May Help Curb Later Drinking, Drug ProblemsNearly 1 in 5 U.S. Adults Has Mental Illness or Drug ProblemCan Fetal Alcohol Damage Be Undone?Hospitalists Have Role to Play in Mitigating Opioid Use DisorderOpioids Second Only to Marijuana in Illicit Drug Abuse RatesEnding U.S. Opioid Abuse Epidemic Will Take Years: ReportMore Research Shows Big Surge in U.S. Opioid Use, AddictionsOpioid Addicts Find It Hard to Avoid Fentanyl
Questions and AnswersLinksBook ReviewsSelf-Help Groups
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Post-Traumatic Stress Disorder

App to Help Treat Substance Abuse Approved

HealthDay News
by -- Scott Roberts
Updated: Sep 14th 2017

THURSDAY, Sept. 14, 2017 (HealthDay News) -- The U.S. Food and Drug Administration has approved its first mobile app to help treat substance abuse, the agency said Thursday in a news release.

The Reset application is designed to help treat abuse of alcohol, cocaine, marijuana and stimulant medications. But the app is not intended for opioid dependence, the FDA said.

Citing the Substance Abuse and Mental Health Services Administration, the FDA said criteria for Substance Use Disorders (SUD) are met when chronic use of these substances causes "significant impairment, such as health problems, disability and failure to meet major responsibilities at work, school or home."

The newly-approved app delivers behavioral therapy that's designed to "increase abstinence from substance abuse and increase [participation] in outpatient therapy programs," the FDA said.

"This is an example of how innovative digital technologies can help provide patients access to additional tools during their treatment," said Carlos Peña, Ph.D., director of the FDA's Division of Neurological and Physical Medicine Devices.

The agency said it reviewed a 12-week clinical study involving nearly 400 people. Among those who used the app, 40.3 percent abstained from further alcohol, cocaine, marijuana or stimulant use, compared with 17.6 percent among those who did not use the app.

Approval of the app was given to Pear Therapeutics, based in Boston and San Francisco.

More information

Visit the FDA to learn more.